European Microbiome Innovation for Health
Budget
€25 — €0
EP Access
0
accredited persons
Staff
5
0.5 FTE
EU Grants
None
Mission & Goals
The European Microbiome Innovation for Health (EMIH) aims to ensure the recognition of microbiota-based medical innovation as a revolutionary and promising sector for patients and economies across the European Union by policymakers and by key healthcare stakeholders. Its members commit to advancing knowledge and fostering therapeutic bioproductions, diagnostics, and medical devices related to the microbiome, particularly in human health. This coalition seeks to ensure equal access to these innovations through a regulatory framework that meets the highest quality standards, while creating a fertile environment for the development of the sector. As an independent coalition spanning across the EU, UK, and Switzerland, EMIH unites pharmaceutical and biotech companies, research institutions, foundations and patient organisations to address unmet medical needs and enhance the quality of life for millions of patients.
EU Legislative Interests
The European Microbiome Innovation for Health (EMIH)’s activities on microbiome innovation cause it to take interest in a wide range of EU initiatives, policies and legislative files relevant to the field including: - EU General Pharmaceutical Legislation - SOHO Regulation - EU BioTech Act - EU Lifesciences Strategy - EU HTA Regulation - Europe’s Beating Cancer Plan and the EU Cancer Mission - European Health Data Space - MD/IVD Regulations - EU Critical Medicines Alliance - EU research programmes: EU4Health Programme / Horizon Europe - EU platforms for collaboration: STEP Platform, IMI Initiative, HERA Industrial Forum - Key initiatives on various topics: addressing healthcare inequalities, prevention, innovation, healthcare across borders, patient Safety, survivorship, Quality of Life and Wellbeing, medicines shortages
Communication Activities
EMIH has drafted a few position papers on the Pharmaceutical Legislation and SoHO but have not been shared publicly yet. A manifesto for 2024-2029 is also available but not yet shared publicly.
Interests Represented
Promotes their own interests or the collective interests of their members
Member Of
We have a partnership with the MTIG https://microbiometig.org/ based in the US.
Organisation Members
https://europeanmicrobiome.org/apm-our-members/
Additional Information
Balance Dec. 31, 2024. All revenues come from the membership fees.
Connected Legislation
Commissioner Meetings
No recorded meetings with EU commissioners.